Valion Bio, Inc. Common Stock

VBIO XNAS • ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

950K

Short interest (Jul 15)

8.2%

Net Short (Jul 27 ): -2.0%

Borrow Fee

13.00%

↑ 1.9%

Available Shares

↓ 100.0%

Price Chart

Company Overview

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Company Info

Exchange: NASDAQ

Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

CIK: 0001787740

Asset Type: CS

Market Data

Market Cap: $950,644

Employees: 52

Status: Active

Short Interest

Current Borrow Fee 13.00%

Range: 13.00% - 13.00%

Available Shares 0

Range: 0 - 15K

Recent Changes

Fee Change: ↑ 14.6%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime